3-(2-piperidin-1-ylethyl)-1H-benzimidazol-2-one structure
|
Common Name | 3-(2-piperidin-1-ylethyl)-1H-benzimidazol-2-one | ||
|---|---|---|---|---|
| CAS Number | 101116-44-3 | Molecular Weight | 245.32000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H19N3O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 3-(2-piperidin-1-ylethyl)-1H-benzimidazol-2-one |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C14H19N3O |
|---|---|
| Molecular Weight | 245.32000 |
| Exact Mass | 245.15300 |
| PSA | 41.29000 |
| LogP | 2.16570 |
|
~%
3-(2-piperidin-... CAS#:101116-44-3 |
| Literature: Cereda, Enzo; Maiocchi, Luciano; Brambilla, Alessandro; Giraldo, Ettore; Monferini, Eugenia; Schiavi, Giovanni Battista Patent: US2003/27823 A1, 2003 ; |
|
~%
3-(2-piperidin-... CAS#:101116-44-3 |
| Literature: NOGRA PHARMA LIMITED; HOMMES, Daan; VERHAAR, Auke; VAN DEN BRINK, Gijs; VITI, Francesca Patent: WO2013/178815 A1, 2013 ; |
|
~%
3-(2-piperidin-... CAS#:101116-44-3 |
| Literature: NOGRA PHARMA LIMITED; HOMMES, Daan; VERHAAR, Auke; VAN DEN BRINK, Gijs; VITI, Francesca Patent: WO2013/178815 A1, 2013 ; Location in patent: Paragraph 00116; 00117 ; |
| 1-[2-(1-piperidinyl)ethyl)-1,3-dihydro-2H-benzimidazol-2-one |
| 2H-Benzimidazol-2-one,1,3-dihydro-1-[2-(1-piperidinyl)ethyl] |
| 1-(2-piperidin-1-ylethyl)-1,3-dihydro-2H-benzimidazol-2-one |
| 1-(2-piperidin-1-yl-ethyl)-1,3-dihydro-benzoimidazol-2-one |